Profil bibliographique

Peter A. Fasching

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

2035Publications signalées

82036Citations signalées

3Affiliations récentes

Institutions déclarées

Friedrich-Alexander-Universität Erlangen-Nürnberg Universitätsklinikum Erlangen Comprehensive Cancer Center Erlangen

Domaines associés

Breast Cancer Treatment StudiesAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchBRCA gene mutations in cancerOvarian cancer diagnosis and treatment

Publications récentes

2026 articleOpenAlex

Clinical Relevance of Post-Treatment Circulating Tumor DNA Detection in Early Breast Cancer Using a Tissue-Free Epigenomic Assay: A 2-Year Landmark Analysis

Thomas W. P. Friedl, Peter A. Fasching, Andreas D. Hartkopf, Hans Tesch et autres

0 citationsJCO Precision Oncology

2026 articleOpenAlex

Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial

Nicholas C. Turner, Erica L. Mayer, Yeon Hee Park, Wolfgang Janni et autres

2 citationsThe Lancet Oncology

2026 conference-paperOpenAlex

Stress Prediction from Temporal Emotion Trajectories in Clinical Patient-Physician Conversations

Tobias Pertlwieser, Hiuching Hung, Tomás Arias-Vergara, Paula Andrea Pérez-Toro et autres

0 citations

Accès ouvert 2026 articleOpenAlex

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A. Zwimpfer, Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne et autres

0 citationsApollo (University of Cambridge)

Accès ouvert 2025 articleOpenAlex

Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX)

Theresa Link, Mattea Reinisch, M. Just, M. Untch et autres

0 citationsESMO Open

2025 articleOpenAlex

Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials

Fabio Conforti, Johannes Holtschmidt, Valentina Nekljudova, Isabella Sala et autres

7 citationsThe Lancet Oncology

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Figures S1-S13 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

Nicola S. Meagher, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon et autres

0 citations

Accès ouvert 2025 otherOpenAlex

Table 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

Nicola S. Meagher, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon et autres

0 citations

Accès ouvert 2025 otherOpenAlex

Figure 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

Nicola S. Meagher, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon et autres

0 citations

Accès ouvert 2025 otherOpenAlex

Figure 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

Nicola S. Meagher, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon et autres

0 citations

Accès ouvert 2025 otherOpenAlex

Table 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

Nicola S. Meagher, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

Nicola S. Meagher, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.